<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01593930</url>
  </required_header>
  <id_info>
    <org_study_id>Articaine pulpal anesthesia</org_study_id>
    <nct_id>NCT01593930</nct_id>
  </id_info>
  <brief_title>Evaluation of the Success Rate of Pulpal Anesthesia in Mandibular First Molar Following Infiltration of 4% Articaine Alone and as Supplemental Injection After Inferior Alveolar Nerve Block</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zahedan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zahedan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the success rate of pulpal anesthesia in mandibular
      firs molar following infiltration of 4% articaine alone and as supplemental injection after
      inferior alveolar nerve block(IANB).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      According to inclusion &amp; exclusion criteria, volunteers will be selected and divided into 4
      groups randomly. The clinician who does the injections will not be aware of study purpose.
      Also the person who does the electric pulp test (EPT); the volunteer and the statistical
      analyzer will not be aware of group codes. Intervention in each group will be as follow:
      Group 1-Buccal infiltration of one 4% Articaine cartridge with 1/100000 epinephrine. Group
      2-Buccal infiltration of two 4% Articaine cartridges with 1/100000epinephrine. Group
      3-Inferior alveolar nerve block using one 2% Lidocaine cartridge with 1/80000 epinephrine +
      buccal infiltration of one 4% Articaine cartridge with 1/100000 epinephrine. Group 4-
      Inferior alveolar nerve block using one 2% Lidocaine cartridge with 1/80000 epinephrine.
      Before injection a control tooth (contralateral canine) will be tested to understand the
      accuracy of patient's response to EPT; also for measuring the base line vitality, each tooth
      will be evaluated by EPT twice before injection. After injection each tooth will be evaluated
      by EPT every 3 minutes; also every minute the anesthesia of lip and tongue will be checked,
      up to 15 minutes. The tooth will be discerned &quot;anesthetized&quot; if the subject will not response
      to 80 reading of EPT in 2 consecutive tests. Finally the information will be recorded and in
      addition to the success rate the mean time for onset of anesthesia and its mean duration time
      will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate</measure>
    <time_frame>Every 3 minutes after injection</time_frame>
    <description>Changes in tooth response to Electric Pulp Tester (EPT) will be checked each 3 minutes after injection. The anesthesia will be considered successful if the subject will not response to EPT at the 80 reading in 2 consecutive tests.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset of anesthesia</measure>
    <time_frame>Every 3 minutes after injection</time_frame>
    <description>Changes in tooth response to Electric Pulp Tester (EPT) will be checked each 3 minutes after injection. No response from the patient at the 80 reading of EPT in 2 consecutive tests will be discerned as &quot;completely anesthetized&quot; and the time will be recorded as &quot;onset of anesthesia&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of anesthesia</measure>
    <time_frame>Every 3 minutes after onset of anesthesia</time_frame>
    <description>Changes in tooth response to Electric Pulp Tester (EPT) will be checked each 3 minutes after onset of anesthesia to determine when the subject will response again at the 80 reading of EPT.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pulpal Anesthesia</condition>
  <arm_group>
    <arm_group_label>1 Articaine(Infiltration)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Buccal infiltration of one 4% Articaine cartridge with 1/100000 epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 Articaine(Infiltration)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Buccal infiltration of two 4% Articaine cartridges with 1/100000 epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine(IANB)+1Articaine(Infiltration)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inferior alveolar nerve block using one 2% Lidocaine cartridge with 1/80000 epinephrine + Buccal infiltration of one 4% Articaine cartridge with 1/100000 epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine(IANB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inferior alveolar nerve block using one 2% Lidocaine cartridge with 1/80000 epinephrine</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lidocaine(IANB)</intervention_name>
    <description>Inferior alveolar nerve block using one 2% Lidocaine cartridge with 1/80000 epinephrine</description>
    <arm_group_label>Lidocaine(IANB)</arm_group_label>
    <other_name>Persocaine E</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>1 Articaine(Infiltration)</intervention_name>
    <description>Buccal infiltration of one 4% Articaine cartridge with 1/100000 epinephrine</description>
    <arm_group_label>1 Articaine(Infiltration)</arm_group_label>
    <other_name>Septanest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2 Articaine(Infiltration)</intervention_name>
    <description>Buccal infiltration of two 4% Articaine cartridges with 1/100000 epinephrine</description>
    <arm_group_label>2 Articaine(Infiltration)</arm_group_label>
    <other_name>Septanest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lidocaine(IANB)+1Articaine(Infiltration)</intervention_name>
    <description>Inferior alveolar nerve block using one 2% Lidocaine cartridge with 1/80000 epinephrine + Buccal infiltration of one 4% Articaine cartridge with 1/100000 epinephrine</description>
    <arm_group_label>Lidocaine(IANB)+1Articaine(Infiltration)</arm_group_label>
    <other_name>Persocaine E + Septanest</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with at least 1 vital first mandibular molar without any restoration or decay

        Exclusion Criteria:

          -  Patients with systemic conditions which eliminate the use of epinephrine

          -  Patients with history of allergy to amide anesthetics or contents of local anesthetic
             cartridge

          -  Pregnant women

          -  Use of analgesics, opioids or any other drugs which influence the anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaveh Oloomi, DDS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zahedan university of medical sciences, Vice-chancellor for research</name>
      <address>
        <city>Zahedan</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2012</study_first_submitted>
  <study_first_submitted_qc>May 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2012</study_first_posted>
  <last_update_submitted>January 28, 2013</last_update_submitted>
  <last_update_submitted_qc>January 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zahedan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Kaveh Oloomi, DDS, MS</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Pulp Anesthesia</keyword>
  <keyword>Articaine</keyword>
  <keyword>Lidocaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Carticaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

